145 related articles for article (PubMed ID: 8291408)
1. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.
Kjaersgaard-Andersen P; Nafei A; Teichert G; Kristensen O; Schmidt SA; Keller J; Lucht U
Acta Orthop Scand; 1993 Dec; 64(6):639-42. PubMed ID: 8291408
[TBL] [Abstract][Full Text] [Related]
2. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
[TBL] [Abstract][Full Text] [Related]
3. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
Hochheim B; Wünsche F
Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
[TBL] [Abstract][Full Text] [Related]
4. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
5. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects.
Cella JP; Salvati EA; Sculco TP
J Arthroplasty; 1988; 3(3):229-34. PubMed ID: 3141590
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report.
Kjaersgaard-Andersen P; Ritter MA
Clin Orthop Relat Res; 1992 Jun; (279):157-62. PubMed ID: 1600651
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty.
Tözün R; Pinar H; Yeşiller E; Hamzaoğlu A
J Arthroplasty; 1992 Mar; 7(1):57-61. PubMed ID: 1564466
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin for prevention of ectopic ossification after hip arthroplasty.
Kjaersgaard-Andersen P; Schmidt SA
Acta Orthop Scand; 1986 Feb; 57(1):12-4. PubMed ID: 3083642
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty.
McMahon JS; Waddell JP; Morton J
J Arthroplasty; 1991 Sep; 6(3):259-64. PubMed ID: 1940932
[TBL] [Abstract][Full Text] [Related]
11. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips.
Gebuhr P; Sletgård J; Dalsgård J; Soelberg M; Keisu K; Hänninen A; Crawford M
Acta Orthop Scand; 1996 Feb; 67(1):29-32. PubMed ID: 8615097
[TBL] [Abstract][Full Text] [Related]
12. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
13. Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen.
Sodemann B; Persson PE; Nilsson OS
Arch Orthop Trauma Surg (1978); 1988; 107(6):329-33. PubMed ID: 3149179
[TBL] [Abstract][Full Text] [Related]
14. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
[TBL] [Abstract][Full Text] [Related]
16. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty.
Kjaersgaard-Andersen P; Schmidt SA; Pedersen NW; Kristensen SS; Pedersen P
Clin Orthop Relat Res; 1989 Nov; (248):189-94. PubMed ID: 2509120
[TBL] [Abstract][Full Text] [Related]
19. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures.
Burd TA; Lowry KJ; Anglen JO
J Bone Joint Surg Am; 2001 Dec; 83(12):1783-8. PubMed ID: 11741055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
